Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Effect of Pasireotide on Glucose- and Growth Hormone-Related Biomarkers in Patients With Inadequately Controlled Acromegaly
Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)
Friedrich, Robert A
When I enrolled in this plan, I did so with the understanding that it provided access to a particular network of physicians and health care systems
US$ 27.10
US$ 23.38
US$ 20.35
